DUBLIN, Oct. 6, 2022 (GLOBE NEWSWIRE) — The “COVID-19-Enabled Global Growth Opportunities for Antimicrobial Technologies” report has been added to ResearchAndMarkets.com’s supply.
Antimicrobial technology has previously been widely used in antimicrobial additives, coatings and films in consumer health applications.
However, with the emergence of COVID-19, the demand for antimicrobial technologies has driven innovation, such as graphene nanoparticles (NPs), photocatalytic additives and antimicrobial polymer nanomaterials, in the development of high-temperature, non-toxic antimicrobial disinfectants and long-term – Enduring adoption of antimicrobial technologies in consumer health, building and construction, automotive and consumer products applications.
Antimicrobial technology materials include antimicrobial polymers; composite materials, metal-based antimicrobials; nanomaterials; natural antimicrobials; antimicrobial peptides (AMPs); and other materials such as phenolic resins, amidines, and biguanides.
Due to their stable structures, metal ions and metal oxide ions have found application in medical and food packaging applications. The use of ultrathin 2D materials such as black phosphorus and graphene on antibacterial surfaces has been the focus of technology development programs following the COVID-19 outbreak.
In addition to antimicrobial surfaces, implants, medical devices, food packaging, construction and construction materials, and textiles are all showing strong interest in antimicrobial coatings.
After COVID-19, the need for active packaging that exhibits high antimicrobial properties in food and personal care applications has prompted industry stakeholders and researchers to continue to use natural antimicrobials such as chitin-chitosan and peptides to Develop biodegradable, safe and efficient active packaging. High performance antimicrobial film.
The research will answer the following questions:
-
What factors will drive the adoption of antimicrobial technologies after COVID-19?
-
What challenges and barriers hinder the adoption of antimicrobial technologies?
-
What are industry players doing to accelerate adoption across industries?
-
What previous challenges have been addressed by adopting antimicrobial technologies across applications?
-
What is the growth potential for the commercialization of antimicrobial technologies across industries?
Key topics covered:
1. Strategic imperatives
-
Why is it getting harder to grow?Strategic imperatives: Factors weighing on growth
-
strategic imperative
-
The impact of three strategic imperatives on COVID-19-enabled antimicrobial technologies
-
Growth Opportunities Drive Growth Pipeline Engines
-
research methodology
2. Research Scope and Segmentation
3. Research summary
4. Analysis of Growth Opportunities: Impact of COVID-19 on Antimicrobial Technologies
-
COVID-19 drives unprecedented demand for antimicrobial technologies
-
AMR Risk and Infection Spread Accelerates Driving Antimicrobial Use in Emerging Markets Before and During COVID-19
-
Technology to adapt antibacterial properties in various applications
-
Metal Ions, Polymers, Natural Substances, AMPs, and Nanobacterials as Interfering Agents for Infection Relief
-
Technology can solve existing AMR challenges post-COVID-19
-
Antimicrobial mode of action defines clinical efficacy through synthesis
-
Antimicrobials paves the way for new applications beyond healthcare
-
Regulatory aspects make commercialization of high-performance antimicrobials time-consuming
5. Technology Assessment: Antimicrobial Technology
-
Metal ions, especially copper and silver, help create new antimicrobial technologies
-
Interest in antibacterial agents that metal and metal oxide ions employ as their stabilizing structures
-
Nanomaterials offer multiple bactericidal pathways to fight microbes and infections
-
Antimicrobial Nanomaterials for High Performance Solutions
-
Food quality and safety awareness creates demand for natural antimicrobials
-
Interest in using natural antimicrobial materials for degradable antimicrobial technology
-
The multifaceted nature of AMPs drives their long-term applicability
-
AMP adoption in healthcare and food packaging applications is increasing
-
Antimicrobial polymers have been shown to protect against the negative effects of pathogenic microorganisms
-
Simplify the manufacturing and application of antimicrobial polymers
-
To assess the impact of antimicrobial susceptibility on outcomes, it is critical to benchmark key performance indicators
-
Relevance of antimicrobial agents in various industrial fields
6. Innovation Ecosystem
-
Commercial metal ion antibacterial technology
-
Develop high-performance antimicrobial coatings using metal ions
-
Nanomaterials for cost-effective, high-performance antimicrobial technology development
-
Research focused on antimicrobial nanomaterial applications in food and energy applications
-
Development of degradable antibacterial films increases
-
Stakeholders investigate potential applications of antimicrobial peptides in food packaging
-
Strong interest in antimicrobial polymer research in Asia Pacific
-
Antimicrobial coatings remain a high R&D area
7. Intellectual property analysis
-
Steady rise in research related to antimicrobial technology
-
Metal ions and natural antibacterial technologies lead global IP filings
-
IP filings at the US and European Patent Offices have risen steadily over the past 5 years
-
Natural antimicrobials are gaining intellectual property attention due to growing interest in developing environmentally friendly technologies
Eight, capital and investment analysis
-
Investors bet on antibiotics to strengthen health and safety during pandemic
-
Funds are mainly used for new product innovation
-
Healthcare companies are key beneficiaries of research into enhanced antimicrobials to fight AMR
-
Antimicrobial spending escalates to eliminate superbug threat
-
Government initiatives and funding as well as private funding to encourage cost-effective antimicrobial technology development
-
Accelerators and incubators accelerate the development of materials and digitalization programs
9. The universe of growth opportunities
-
Growth Opportunity 1: Development of Ultra-thin, Durable, High-Performance Antibacterial Technology
-
Growth Opportunity 2 Integration of Nanomaterials in Manufacturing Processes for Cost-Effective and High-Performance Antimicrobial Technologies
-
Growth Opportunity 3: R&D activities to develop self-disinfection technology using metal and metal oxide ions
-
Growth Opportunity 4: Digital interventions in antimicrobial stewardship can drive new product development
10. Appendix
For more information on this report, please visit https://www.researchandmarkets.com/r/wpthk2
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
